Safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with moderate or severe Haemophilia A in India.
Phase of Trial: Phase IV
Latest Information Update: 25 May 2018
At a glance
- Drugs Turoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms guardian TM 10
- Sponsors Novo Nordisk
- 02 Mar 2018 Status changed from not stated to recruiting.
- 22 Feb 2018 New trial record